Human plasma in the production of medicinal products: national differences in terms of harmonization with global compendial requirements

INTRODUCTION. Plasma-derived medicinal products (PDMPs) are used to treat a number of systemic diseases, immunodeficiency disorders, and life-threatening conditions.  The  growing PDMP consumption necessitates the scaling of production and the provision of a stable supply of plasma, with the quality...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	О. A. Demidova, O. G. Kornilova, O. V. Muslimova, V. L. Bagirova
Hōputu:	Artigo
Reo:	Russo
I whakaputaina:	Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2026-04-01
Rangatū:	Биопрепараты: Профилактика, диагностика, лечение
Ngā marau:	стандартизация плазма крови человека доноры карантинизация индивидуальные донации пулы плазмы вирусная безопасность фармакопейная статья гармонизация государственная фармакопея российской федерации европейская фармакопея
Urunga tuihono:	https://www.biopreparations.ru/jour/article/view/757
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!